Geron (GERN) Net Equity Issued and Repurchased (2010 - 2021)
Geron (GERN) posted Net Equity Issued and Repurchased of $4.2 million for Q4 2021, down 74.43% sequentially from $16.2 million in Q1 2021.
Geron (GERN) Net Equity Issued and Repurchased (2010 - 2021) Analysis & Trends
Geron has reported Net Equity Issued and Repurchased for 12 years, with the latest figure at $4.2 million in Q4 2021.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $4.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $20.4 million (up 400.25% YoY) and the FY2021 annual result came in at $20.4 million, up 400.25% from the prior year.
- Net Equity Issued and Repurchased declined to $4.2 million in Q4 2021 per GERN's latest filing, from $16.2 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $82.3 million in Q2 2018 and troughed at -$6.9 million in Q4 2018.
- A 5-year average of $11.9 million and a median of $4.2 million in 2021 frame the typical range for Net Equity Issued and Repurchased.
- The sharpest annual moves came in 2017 and 2018: Net Equity Issued and Repurchased jumped 8425.0% in 2017, then plunged 778.69% in 2018.
- Over 5 years, Net Equity Issued and Repurchased stood at $1.0 million in 2017, then slumped by 778.69% to -$6.9 million in 2018, then soared by 247.41% to $10.2 million in 2019, then plunged by 66.89% to $3.4 million in 2020, then climbed by 22.48% to $4.2 million in 2021.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $4.2 million, $16.2 million, and $3.4 million for Q4 2021, Q1 2021, and Q2 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Geron | 1.02 Mn | -299.83 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 4.15 Mn |
| Dec 31, 2021 | 4.15 Mn |
| Mar 31, 2021 | 16.23 Mn |
| Mar 31, 2021 | 16.23 Mn |
| Jun 30, 2020 | 3.39 Mn |
| Jun 30, 2020 | 3.39 Mn |
| Mar 31, 2020 | 686,000.00 |
| Mar 31, 2020 | 686,000.00 |
| Dec 31, 2019 | 10.24 Mn |
| Dec 31, 2019 | 10.24 Mn |
| Sep 30, 2019 | 8.82 Mn |
| Sep 30, 2019 | 8.82 Mn |
| Dec 31, 2018 | -6.94 Mn |
| Dec 31, 2018 | -6.94 Mn |
| Sep 30, 2018 | 9.09 Mn |
| Sep 30, 2018 | 9.09 Mn |
| Jun 30, 2018 | 82.32 Mn |
| Jun 30, 2018 | 82.32 Mn |
| Mar 31, 2018 | 1.55 Mn |
| Mar 31, 2018 | 1.55 Mn |